Ardelyx, Inc. (ARDX)
7.00
+1.17
(+20.07%)
USD |
NASDAQ |
Jan 08, 16:00
7.18
+0.18
(+2.57%)
After-Hours: 07:55
Ardelyx EPS Diluted (Quarterly): -0.004 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Johnson & Johnson | 2.121 |
| AbbVie, Inc. | 0.0993 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.969M |
| Revenue (Quarterly) | 110.33M |
| Total Expenses (Quarterly) | 111.30M |
| Enterprise Value | 1.666B |
| Gross Profit Margin (Quarterly) | 95.57% |
| Profit Margin (Quarterly) | -0.88% |
| Earnings Yield | -3.38% |
| Normalized Earnings Yield | -3.384 |